TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global and United States Vitamin K Antagonists (VKA) Market Report & Forecast 2022-2028

Global and United States Vitamin K Antagonists (VKA) Market Report & Forecast 2022-2028

  • Category:Life Sciences
  • Published on : 23 September 2022
  • Pages :108
  • Formats:
  • Report Code:SMR-7383574
OfferClick for best price

Best Price: $2393

Market Analysis and Insights: Global Vitamin K Antagonists VKA Market

The global Vitamin K Antagonists VKA market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Vitamin K Antagonists VKA market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Vitamin K Antagonists VKA market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Vitamin K Antagonists VKA market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Vitamin K Antagonists VKA market.

Global Vitamin K Antagonists VKA Scope and Market Size

Vitamin K Antagonists (VKA) market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Vitamin K Antagonists (VKA) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Vitamin K Antagonists (VKA) market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Oral Vitamin K Antagonists
Injection Vitamin K Antagonists
Segment by Application
VTE
ACS/MI
AF
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Sanofi
Bristol-Myers Squibb
Bayer
Johnson & Johnson
Genentech (Roche)
Boehringer Ingelheim
Lilly
Daiichi Sankyo
Otsuka
AstraZeneca
Pfizer
Aspen
The Medicines Company

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Vitamin K Antagonists VKA product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Vitamin K Antagonists VKA, with price, sales, revenue, and global market share of Vitamin K Antagonists VKA from 2019 to 2022.

Chapter 3, the Vitamin K Antagonists VKA competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Vitamin K Antagonists VKA breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Vitamin K Antagonists VKA market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Vitamin K Antagonists VKA.

Chapter 13, 14, and 15, to describe Vitamin K Antagonists VKA sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Vitamin K Antagonists VKA Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

TABLE OF CONTENTS

1 Study Coverage
1.1 Vitamin K Antagonists (VKA) Product Introduction
1.2 Global Vitamin K Antagonists (VKA) Outlook 2017 VS 2022 VS 2028
1.2.1 Global Vitamin K Antagonists (VKA) Sales in US$ Million for the Year 2017-2028
1.2.2 Global Vitamin K Antagonists (VKA) Sales in Volume for the Year 2017-2028
1.3 United States Vitamin K Antagonists (VKA) Outlook 2017 VS 2022 VS 2028
1.3.1 United States Vitamin K Antagonists (VKA) Sales in US$ Million for the Year 2017-2028
1.3.2 United States Vitamin K Antagonists (VKA) Sales in Volume for the Year 2017-2028
1.4 Vitamin K Antagonists (VKA) Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Vitamin K Antagonists (VKA) in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Vitamin K Antagonists (VKA) Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Vitamin K Antagonists (VKA) Market Dynamics
1.5.1 Vitamin K Antagonists (VKA) Industry Trends
1.5.2 Vitamin K Antagonists (VKA) Market Drivers
1.5.3 Vitamin K Antagonists (VKA) Market Challenges
1.5.4 Vitamin K Antagonists (VKA) Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Vitamin K Antagonists (VKA) Market Segment by Type
2.1.1 Oral Vitamin K Antagonists
2.1.2 Injection Vitamin K Antagonists
2.2 Global Vitamin K Antagonists (VKA) Market Size by Type
2.2.1 Global Vitamin K Antagonists (VKA) Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Vitamin K Antagonists (VKA) Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Vitamin K Antagonists (VKA) Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Vitamin K Antagonists (VKA) Market Size by Type
2.3.1 United States Vitamin K Antagonists (VKA) Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Vitamin K Antagonists (VKA) Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Vitamin K Antagonists (VKA) Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Vitamin K Antagonists (VKA) Market Segment by Application
3.1.1 VTE
3.1.2 ACS/MI
3.1.3 AF
3.1.4 Others
3.2 Global Vitamin K Antagonists (VKA) Market Size by Application
3.2.1 Global Vitamin K Antagonists (VKA) Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Vitamin K Antagonists (VKA) Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Vitamin K Antagonists (VKA) Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Vitamin K Antagonists (VKA) Market Size by Application
3.3.1 United States Vitamin K Antagonists (VKA) Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Vitamin K Antagonists (VKA) Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Vitamin K Antagonists (VKA) Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Vitamin K Antagonists (VKA) Competitor Landscape by Company
4.1 Global Vitamin K Antagonists (VKA) Market Size by Company
4.1.1 Top Global Vitamin K Antagonists (VKA) Manufacturers Ranked by Revenue (2021)
4.1.2 Global Vitamin K Antagonists (VKA) Revenue by Manufacturer (2017-2022)
4.1.3 Global Vitamin K Antagonists (VKA) Sales by Manufacturer (2017-2022)
4.1.4 Global Vitamin K Antagonists (VKA) Price by Manufacturer (2017-2022)
4.2 Global Vitamin K Antagonists (VKA) Concentration Ratio (CR)
4.2.1 Vitamin K Antagonists (VKA) Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Vitamin K Antagonists (VKA) in 2021
4.2.3 Global Vitamin K Antagonists (VKA) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Vitamin K Antagonists (VKA) Manufacturing Base Distribution, Product Type
4.3.1 Global Vitamin K Antagonists (VKA) Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Vitamin K Antagonists (VKA) Product Type
4.3.3 Date of International Manufacturers Enter into Vitamin K Antagonists (VKA) Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Vitamin K Antagonists (VKA) Market Size by Company
4.5.1 Top Vitamin K Antagonists (VKA) Players in United States, Ranked by Revenue (2021)
4.5.2 United States Vitamin K Antagonists (VKA) Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Vitamin K Antagonists (VKA) Sales by Players (2020, 2021 & 2022)
5 Global Vitamin K Antagonists (VKA) Market Size by Region
5.1 Global Vitamin K Antagonists (VKA) Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Vitamin K Antagonists (VKA) Market Size in Volume by Region (2017-2028)
5.2.1 Global Vitamin K Antagonists (VKA) Sales in Volume by Region: 2017-2022
5.2.2 Global Vitamin K Antagonists (VKA) Sales in Volume Forecast by Region (2023-2028)
5.3 Global Vitamin K Antagonists (VKA) Market Size in Value by Region (2017-2028)
5.3.1 Global Vitamin K Antagonists (VKA) Sales in Value by Region: 2017-2022
5.3.2 Global Vitamin K Antagonists (VKA) Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Vitamin K Antagonists (VKA) Market Size YoY Growth 2017-2028
6.1.2 North America Vitamin K Antagonists (VKA) Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Vitamin K Antagonists (VKA) Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Vitamin K Antagonists (VKA) Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Vitamin K Antagonists (VKA) Market Size YoY Growth 2017-2028
6.3.2 Europe Vitamin K Antagonists (VKA) Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Vitamin K Antagonists (VKA) Market Size YoY Growth 2017-2028
6.4.2 Latin America Vitamin K Antagonists (VKA) Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Vitamin K Antagonists (VKA) Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Vitamin K Antagonists (VKA) Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Sanofi
7.1.1 Sanofi Corporation Information
7.1.2 Sanofi Description and Business Overview
7.1.3 Sanofi Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Sanofi Vitamin K Antagonists (VKA) Products Offered
7.1.5 Sanofi Recent Development
7.2 Bristol-Myers Squibb
7.2.1 Bristol-Myers Squibb Corporation Information
7.2.2 Bristol-Myers Squibb Description and Business Overview
7.2.3 Bristol-Myers Squibb Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Bristol-Myers Squibb Vitamin K Antagonists (VKA) Products Offered
7.2.5 Bristol-Myers Squibb Recent Development
7.3 Bayer
7.3.1 Bayer Corporation Information
7.3.2 Bayer Description and Business Overview
7.3.3 Bayer Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Bayer Vitamin K Antagonists (VKA) Products Offered
7.3.5 Bayer Recent Development
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Corporation Information
7.4.2 Johnson & Johnson Description and Business Overview
7.4.3 Johnson & Johnson Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Johnson & Johnson Vitamin K Antagonists (VKA) Products Offered
7.4.5 Johnson & Johnson Recent Development
7.5 Genentech (Roche)
7.5.1 Genentech (Roche) Corporation Information
7.5.2 Genentech (Roche) Description and Business Overview
7.5.3 Genentech (Roche) Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Genentech (Roche) Vitamin K Antagonists (VKA) Products Offered
7.5.5 Genentech (Roche) Recent Development
7.6 Boehringer Ingelheim
7.6.1 Boehringer Ingelheim Corporation Information
7.6.2 Boehringer Ingelheim Description and Business Overview
7.6.3 Boehringer Ingelheim Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Boehringer Ingelheim Vitamin K Antagonists (VKA) Products Offered
7.6.5 Boehringer Ingelheim Recent Development
7.7 Lilly
7.7.1 Lilly Corporation Information
7.7.2 Lilly Description and Business Overview
7.7.3 Lilly Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Lilly Vitamin K Antagonists (VKA) Products Offered
7.7.5 Lilly Recent Development
7.8 Daiichi Sankyo
7.8.1 Daiichi Sankyo Corporation Information
7.8.2 Daiichi Sankyo Description and Business Overview
7.8.3 Daiichi Sankyo Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Daiichi Sankyo Vitamin K Antagonists (VKA) Products Offered
7.8.5 Daiichi Sankyo Recent Development
7.9 Otsuka
7.9.1 Otsuka Corporation Information
7.9.2 Otsuka Description and Business Overview
7.9.3 Otsuka Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Otsuka Vitamin K Antagonists (VKA) Products Offered
7.9.5 Otsuka Recent Development
7.10 AstraZeneca
7.10.1 AstraZeneca Corporation Information
7.10.2 AstraZeneca Description and Business Overview
7.10.3 AstraZeneca Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2017-2022)
7.10.4 AstraZeneca Vitamin K Antagonists (VKA) Products Offered
7.10.5 AstraZeneca Recent Development
7.11 Pfizer
7.11.1 Pfizer Corporation Information
7.11.2 Pfizer Description and Business Overview
7.11.3 Pfizer Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Pfizer Vitamin K Antagonists (VKA) Products Offered
7.11.5 Pfizer Recent Development
7.12 Aspen
7.12.1 Aspen Corporation Information
7.12.2 Aspen Description and Business Overview
7.12.3 Aspen Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Aspen Products Offered
7.12.5 Aspen Recent Development
7.13 The Medicines Company
7.13.1 The Medicines Company Corporation Information
7.13.2 The Medicines Company Description and Business Overview
7.13.3 The Medicines Company Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2017-2022)
7.13.4 The Medicines Company Products Offered
7.13.5 The Medicines Company Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Vitamin K Antagonists (VKA) Industry Chain Analysis
8.2 Vitamin K Antagonists (VKA) Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Vitamin K Antagonists (VKA) Distributors
8.3 Vitamin K Antagonists (VKA) Production Mode & Process
8.4 Vitamin K Antagonists (VKA) Sales and Marketing
8.4.1 Vitamin K Antagonists (VKA) Sales Channels
8.4.2 Vitamin K Antagonists (VKA) Distributors
8.5 Vitamin K Antagonists (VKA) Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Vitamin K Antagonists (VKA) CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Vitamin K Antagonists (VKA) Market Trends
Table 3. Vitamin K Antagonists (VKA) Market Drivers
Table 4. Vitamin K Antagonists (VKA) Market Challenges
Table 5. Vitamin K Antagonists (VKA) Market Restraints
Table 6. Global Vitamin K Antagonists (VKA) Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Vitamin K Antagonists (VKA) Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Vitamin K Antagonists (VKA) Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Vitamin K Antagonists (VKA) Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Vitamin K Antagonists (VKA) Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Vitamin K Antagonists (VKA) Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Vitamin K Antagonists (VKA) Revenue Share by Manufacturer, 2017-2022
Table 13. Global Vitamin K Antagonists (VKA) Sales by Manufacturer, (K MT), 2017-2022
Table 14. Global Vitamin K Antagonists (VKA) Sales Share by Manufacturer, 2017-2022
Table 15. Global Vitamin K Antagonists (VKA) Price by Manufacturer (2017-2022) & (USD/MT)
Table 16. Global Vitamin K Antagonists (VKA) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Vitamin K Antagonists (VKA) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vitamin K Antagonists (VKA) as of 2021)
Table 18. Top Players of Vitamin K Antagonists (VKA) in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Vitamin K Antagonists (VKA) Product Type
Table 20. Date of International Manufacturers Enter into Vitamin K Antagonists (VKA) Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Vitamin K Antagonists (VKA) Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Vitamin K Antagonists (VKA) Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Vitamin K Antagonists (VKA) Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Vitamin K Antagonists (VKA) Sales by Players, (K MT), 2020, 2021 & 2022
Table 26. United States Vitamin K Antagonists (VKA) Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Vitamin K Antagonists (VKA) Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Vitamin K Antagonists (VKA) Sales in Volume by Region (2017-2022) & (K MT)
Table 29. Global Vitamin K Antagonists (VKA) Sales in Volume Forecast by Region (2023-2028) & (K MT)
Table 30. Global Vitamin K Antagonists (VKA) Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Vitamin K Antagonists (VKA) Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Vitamin K Antagonists (VKA) Sales in Volume by Country (2017-2028) & (K MT)
Table 33. North America Vitamin K Antagonists (VKA) Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Vitamin K Antagonists (VKA) Sales in Volume by Region (2017-2028) & (K MT)
Table 35. Asia Pacific Vitamin K Antagonists (VKA) Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Vitamin K Antagonists (VKA) Sales in Volume by Country (2017-2028) & (K MT)
Table 37. Europe Vitamin K Antagonists (VKA) Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Vitamin K Antagonists (VKA) Sales in Volume by Country (2017-2028) & (K MT)
Table 39. Latin Americaa Vitamin K Antagonists (VKA) Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Vitamin K Antagonists (VKA) Sales in Volume by Country (2017-2028) & (K MT)
Table 41. Middle East and Africa Vitamin K Antagonists (VKA) Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Sanofi Corporation Information
Table 43. Sanofi Description and Business Overview
Table 44. Sanofi Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 45. Sanofi Vitamin K Antagonists (VKA) Product
Table 46. Sanofi Recent Development
Table 47. Bristol-Myers Squibb Corporation Information
Table 48. Bristol-Myers Squibb Description and Business Overview
Table 49. Bristol-Myers Squibb Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 50. Bristol-Myers Squibb Product
Table 51. Bristol-Myers Squibb Recent Development
Table 52. Bayer Corporation Information
Table 53. Bayer Description and Business Overview
Table 54. Bayer Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 55. Bayer Product
Table 56. Bayer Recent Development
Table 57. Johnson & Johnson Corporation Information
Table 58. Johnson & Johnson Description and Business Overview
Table 59. Johnson & Johnson Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 60. Johnson & Johnson Product
Table 61. Johnson & Johnson Recent Development
Table 62. Genentech (Roche) Corporation Information
Table 63. Genentech (Roche) Description and Business Overview
Table 64. Genentech (Roche) Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 65. Genentech (Roche) Product
Table 66. Genentech (Roche) Recent Development
Table 67. Boehringer Ingelheim Corporation Information
Table 68. Boehringer Ingelheim Description and Business Overview
Table 69. Boehringer Ingelheim Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 70. Boehringer Ingelheim Product
Table 71. Boehringer Ingelheim Recent Development
Table 72. Lilly Corporation Information
Table 73. Lilly Description and Business Overview
Table 74. Lilly Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 75. Lilly Product
Table 76. Lilly Recent Development
Table 77. Daiichi Sankyo Corporation Information
Table 78. Daiichi Sankyo Description and Business Overview
Table 79. Daiichi Sankyo Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 80. Daiichi Sankyo Product
Table 81. Daiichi Sankyo Recent Development
Table 82. Otsuka Corporation Information
Table 83. Otsuka Description and Business Overview
Table 84. Otsuka Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 85. Otsuka Product
Table 86. Otsuka Recent Development
Table 87. AstraZeneca Corporation Information
Table 88. AstraZeneca Description and Business Overview
Table 89. AstraZeneca Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 90. AstraZeneca Product
Table 91. AstraZeneca Recent Development
Table 92. Pfizer Corporation Information
Table 93. Pfizer Description and Business Overview
Table 94. Pfizer Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 95. Pfizer Product
Table 96. Pfizer Recent Development
Table 97. Aspen Corporation Information
Table 98. Aspen Description and Business Overview
Table 99. Aspen Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 100. Aspen Product
Table 101. Aspen Recent Development
Table 102. The Medicines Company Corporation Information
Table 103. The Medicines Company Description and Business Overview
Table 104. The Medicines Company Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 105. The Medicines Company Product
Table 106. The Medicines Company Recent Development
Table 107. Key Raw Materials Lists
Table 108. Raw Materials Key Suppliers Lists
Table 109. Vitamin K Antagonists (VKA) Customers List
Table 110. Vitamin K Antagonists (VKA) Distributors List
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Vitamin K Antagonists (VKA) Product Picture
Figure 2. Global Vitamin K Antagonists (VKA) Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Vitamin K Antagonists (VKA) Market Size 2017-2028 (US$ Million)
Figure 4. Global Vitamin K Antagonists (VKA) Sales 2017-2028 (K MT)
Figure 5. United States Vitamin K Antagonists (VKA) Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Vitamin K Antagonists (VKA) Market Size 2017-2028 (US$ Million)
Figure 7. United States Vitamin K Antagonists (VKA) Sales 2017-2028 (K MT)
Figure 8. United States Vitamin K Antagonists (VKA) Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Vitamin K Antagonists (VKA) Market Share in Global, in Volume (K MT) 2017-2028
Figure 10. Vitamin K Antagonists (VKA) Report Years Considered
Figure 11. Product Picture of Oral Vitamin K Antagonists
Figure 12. Product Picture of Injection Vitamin K Antagonists
Figure 13. Global Vitamin K Antagonists (VKA) Market Share by Type in 2022 & 2028
Figure 14. Global Vitamin K Antagonists (VKA) Sales in Value by Type (2017-2028) & (US$ Million)
Figure 15. Global Vitamin K Antagonists (VKA) Sales Market Share in Value by Type (2017-2028)
Figure 16. Global Vitamin K Antagonists (VKA) Sales by Type (2017-2028) & (K MT)
Figure 17. Global Vitamin K Antagonists (VKA) Sales Market Share in Volume by Type (2017-2028)
Figure 18. Global Vitamin K Antagonists (VKA) Price by Type (2017-2028) & (USD/MT)
Figure 19. United States Vitamin K Antagonists (VKA) Market Share by Type in 2022 & 2028
Figure 20. United States Vitamin K Antagonists (VKA) Sales in Value by Type (2017-2028) & (US$ Million)
Figure 21. United States Vitamin K Antagonists (VKA) Sales Market Share in Value by Type (2017-2028)
Figure 22. United States Vitamin K Antagonists (VKA) Sales by Type (2017-2028) & (K MT)
Figure 23. United States Vitamin K Antagonists (VKA) Sales Market Share in Volume by Type (2017-2028)
Figure 24. United States Vitamin K Antagonists (VKA) Price by Type (2017-2028) & (USD/MT)
Figure 25. Product Picture of VTE
Figure 26. Product Picture of ACS/MI
Figure 27. Product Picture of AF
Figure 28. Product Picture of Others
Figure 29. Global Vitamin K Antagonists (VKA) Market Share by Application in 2022 & 2028
Figure 30. Global Vitamin K Antagonists (VKA) Sales in Value by Application (2017-2028) & (US$ Million)
Figure 31. Global Vitamin K Antagonists (VKA) Sales Market Share in Value by Application (2017-2028)
Figure 32. Global Vitamin K Antagonists (VKA) Sales by Application (2017-2028) & (K MT)
Figure 33. Global Vitamin K Antagonists (VKA) Sales Market Share in Volume by Application (2017-2028)
Figure 34. Global Vitamin K Antagonists (VKA) Price by Application (2017-2028) & (USD/MT)
Figure 35. United States Vitamin K Antagonists (VKA) Market Share by Application in 2022 & 2028
Figure 36. United States Vitamin K Antagonists (VKA) Sales in Value by Application (2017-2028) & (US$ Million)
Figure 37. United States Vitamin K Antagonists (VKA) Sales Market Share in Value by Application (2017-2028)
Figure 38. United States Vitamin K Antagonists (VKA) Sales by Application (2017-2028) & (K MT)
Figure 39. United States Vitamin K Antagonists (VKA) Sales Market Share in Volume by Application (2017-2028)
Figure 40. United States Vitamin K Antagonists (VKA) Price by Application (2017-2028) & (USD/MT)
Figure 41. North America Vitamin K Antagonists (VKA) Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 42. North America Vitamin K Antagonists (VKA) Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 43. U.S. Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Canada Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Europe Vitamin K Antagonists (VKA) Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 46. Europe Vitamin K Antagonists (VKA) Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 47. Germany Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. France Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. U.K. Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Italy Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Russia Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Asia-Pacific Vitamin K Antagonists (VKA) Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 53. Asia-Pacific Vitamin K Antagonists (VKA) Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 54. China Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. Japan Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. South Korea Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. India Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Australia Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Taiwan Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Indonesia Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Thailand Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Malaysia Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Philippines Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Latin America Vitamin K Antagonists (VKA) Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 65. Latin America Vitamin K Antagonists (VKA) Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 66. Mexico Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Brazil Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Argentina Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Middle East & Africa Vitamin K Antagonists (VKA) Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 70. Middle East & Africa Vitamin K Antagonists (VKA) Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 71. Turkey Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Saudi Arabia Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. UAE Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. Vitamin K Antagonists (VKA) Value Chain
Figure 75. Vitamin K Antagonists (VKA) Production Process
Figure 76. Channels of Distribution
Figure 77. Distributors Profiles
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed

PURCHASE OPTIONS

USD GBP EURO YEN Single User Price
USD GBP EURO YEN Multi User Price
USD GBP EURO YEN Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount